Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

D,L-fenfluramine challenge test: experience in nonpatient sample

M F Muldoon1, S B Manuck, C L Jansma

  • 1Center for Clinical Pharmacology, University of Pittsburgh School of Medicine, PA, USA.

Biological Psychiatry
|May 1, 1996
PubMed
Summary

Fenfluramine challenge tests measure central serotonergic activity by tracking plasma prolactin response. This response, and associated side effects, are significantly influenced by weight-relative dosage in non-patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mn-porphyrins in a four-helix bundle participate in photo-induced electron transfer with a bacterial reaction center.

Photosynthesis research·2023
Same author

Occurrence and greater intensity of estrus in recipient lactating dairy cows improve pregnancy per embryo transfer.

Journal of dairy science·2021
Same author

Psychotropic and neurological medication effects on mitochondrial complex I and IV in rodent models.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology·2019
Same author

Antidepressant medication exposure and 5-HT<sub>1A</sub> autoreceptor binding in major depressive disorder.

Synapse (New York, N.Y.)·2019
Same author

Multivariate meta-analyses of mitochondrial complex I and IV in major depressive disorder, bipolar disorder, schizophrenia, Alzheimer disease, and Parkinson disease.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2018
Same author

Region-specific alterations of A-to-I RNA editing of serotonin 2c receptor in the cortex of suicides with major depression.

Translational psychiatry·2016

Area of Science:

  • Neuroscience
  • Psychopharmacology
  • Clinical Research

Background:

  • The fenfluramine challenge test is a key tool for assessing central serotonergic activity.
  • Factors like age, gender, and body weight effects on this test are not well understood.
  • Characterizing fenfluramine-induced symptoms is crucial for its application.

Purpose of the Study:

  • To investigate the impact of age, gender, and body weight on plasma prolactin response to fenfluramine.
  • To characterize the physical and psychological symptoms elicited by fenfluramine.
  • To establish guidelines for reporting fenfluramine challenge test results.

Main Methods:

  • 83 non-patient volunteers (25-60 years old) underwent a standardized 60 mg fenfluramine challenge.
  • Serial blood samples measured plasma drug and prolactin concentrations.

Related Experiment Videos

  • Participant-reported side effects were systematically recorded.

    • Main Results:

    • Plasma drug concentration and prolactin response correlated with weight-relative dose (r=0.43, r=0.38).
    • No significant correlations were found between prolactin response and age or gender.
    • 90% of subjects reported symptoms (fatigue, headache, lightheadedness, concentration difficulties); severity linked to dose and prolactin response.

    Conclusions:

    • Fenfluramine challenge test results, particularly prolactin changes, should be reported relative to the administered dose.
    • The test is associated with frequent side effects in non-patient populations.
    • Weight-relative dosing is a critical factor in interpreting fenfluramine challenge outcomes.